SCHEMBL30375620

SCHEMBL30375620

Cn1cc2c3cc(C(=O)NCCO)ccc3n(-c3ccc(C(F)(F)F)cc3)c2n1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TEAD1 P28347 1/20 0.72
TEAD4 Q15561 1/20 0.72
TEAD2 Q15562 1/20 0.72
TEAD3 Q99594 1/20 0.72
METAP2 P50579 5/20 0.46
CYP1A2 P05177 3/20 0.46
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
GPR52 Q9Y2T5 3/20 0.39
MCHR1 Q99705 1/20 0.38
MAPK8 P45983 1/20 0.38
MAPK9 P45984 1/20 0.38
MAPK10 P53779 1/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SCN5A Q14524 1/20 0.38
SCN9A Q15858 1/20 0.38
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24015683 1.00 TEAD1 (0.72) TEAD1TEAD4TEAD2TEAD3METAP2
SCHEMBL25205098 0.94 TEAD1 (0.69) TEAD1TEAD4TEAD2TEAD3METAP2
SCHEMBL30375250 0.94 TEAD1 (0.69) TEAD1TEAD4TEAD2TEAD3METAP2
SCHEMBL24016563 0.93 TEAD1 (0.72) TEAD1TEAD4TEAD2TEAD3CYP1A2
SCHEMBL24016194 0.92 TEAD1 (0.71) TEAD1TEAD4TEAD2TEAD3METAP2
SCHEMBL30376337 0.92 TEAD1 (0.71) TEAD1TEAD4TEAD2TEAD3METAP2
SCHEMBL25193481 0.92 TEAD1 (0.71) TEAD1TEAD4TEAD2TEAD3METAP2
SCHEMBL24015676 0.91 TEAD1 (0.69) TEAD1TEAD4TEAD2TEAD3CYP1A2
SCHEMBL25192817 0.90 TEAD1 (0.64) TEAD1TEAD4TEAD2TEAD3METAP2
SCHEMBL30376313 0.90 TEAD1 (0.64) TEAD1TEAD4TEAD2TEAD3METAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250032625-A1 HETEROBIFUNCTIONAL MOLECULES AS TEAD INHIBITORS Merck Patent KGaA (DE) 2025-01-30 US disclosed
EP-4426700-A1 HETEROBIFUNCTIONAL MOLECULES AS TEAD INHIBITORS Merck Patent GmbH (DE) 2024-09-11 EP disclosed
WO-2023078813-A1 HETEROBIFUNCTIONAL MOLECULES AS TEAD INHIBITORS MERCK PATENT GMBH (DE) 2023-05-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250032625-A1 HETEROBIFUNCTIONAL MOLECULES AS TEAD INHIBITORS TEAD1, UBQLN1, TTI1 TEAD1 1/4885TEAD4 9/4885TEAD2 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.